Nouvelles & Évènements
- Tout
- Prix
- Communauté
- Profil du Réseau
- Communiqué de presse
- Points saillants de la recherche
Unlocking the door to potential therapeutic treatments for serious complications from infections
GlycoNet scientists solved the structure of an enzyme that could help burn victims and prevent deaths from different kinds of infections.
How a protein in your brain could protect against Alzheimer’s disease
GlycoNet Investigator sets the stage for new therapeutic strategies for Alzheimer’s disease.
Potent antimicrobial found that shows promise in fighting staph infections
GlycoNet researchers discovered a molecule against Methicillin-resistant (MRSA) bacteria.
The secret life of bacterial phosphonate biosynthesis, revealed
GlycoNet scientists identified an enzyme possibly related to bacterial virulence and antibiotic resistance.
GlycoNet research team uses bacterial enzymes to boost the expression of human polysialyltransferase
The direct biochemical approach helps direct cells to specific sites for more efficient and targeted treatment.
Harnessing the power of glycomics to improve drugs
Glycoscience expert Warren Wakarchuk is a Professor and Associate Scientific Director of the Canadian Glycomics Network
Announcing the GlycoNet travel award winners for the Canadian Science Policy Conference
Four Network trainees will participate in the conference where they will be exposed to a wide spectrum of topics and pressing issues in science and innovation policy
Graphic: About GlycoNet
Since its launch in 2015, GlycoNet has committed to research and training activities across Canada, striving to deliver concrete solutions to health issues.
Tracing the path of Parkinson’s disease
Like a GPS, this tracer could identify and monitor the disease progression
French 
English